Home/Filings/4/0001213900-25-095391
4//SEC Filing

Graff Jeremy R. 4

Accession 0001213900-25-095391

CIK 0001860657other

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 4:05 PM ET

Size

8.6 KB

Accession

0001213900-25-095391

Insider Transaction Report

Form 4
Period: 2025-09-30
Graff Jeremy R.
See Remarks
Transactions
  • Exercise/Conversion

    Common Stock

    2025-09-30+39,49439,494 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-09-3039,494223,430 total
    Common Stock (39,494 underlying)
  • Tax Payment

    Common Stock

    2025-09-30$1.58/sh14,613$23,08924,881 total
Footnotes (2)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]On September 30, 2024 and January 22, 2025, the Reporting Person was granted 118,483 and 144,441 restricted stock units, respectively, which vest in three equal annual installments beginning on the first anniversary of the applicable grant date.

Documents

1 file

Issuer

Allarity Therapeutics, Inc.

CIK 0001860657

Entity typeother

Related Parties

1
  • filerCIK 0001975028

Filing Metadata

Form type
4
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 4:05 PM ET
Size
8.6 KB